Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris CAC 40 luxury group (Euronext: KER) owning Gucci/Saint Laurent/Bottega Veneta/Balenciaga; new CEO Luca de Meo (Sep 2025) tasked with Gucci revenue recovery competing with LVMH for ultra-luxury market share.
Kering S.A. is a Paris, France-based global luxury goods group — publicly traded on Euronext Paris (EPA: KER) as a CAC 40 component — owning and operating a portfolio of iconic luxury fashion, leather goods, jewelry, and eyewear houses including Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Brioni, Boucheron, Pomellato, DoDo, Qeelin, and Kering Eyewear through approximately 47,000 employees and 1,813 directly operated stores worldwide. Founded in 1962 by François Pinault as a timber and building materials trading company, Kering (formerly Pinault-Printemps-Redoute, then PPR) transformed into a luxury group through landmark acquisitions: Gucci Group in 1999 ($3 billion, acquiring Gucci, Saint Laurent, Bottega Veneta, Balenciaga, and Alexander McQueen), rebranding from PPR to Kering in 2013 to signal the luxury focus. François-Henri Pinault (François's son) served as Chairman and CEO for nearly two decades before Luca de Meo was appointed CEO in September 2025 — with François-Henri remaining as Executive Chairman. Kering generates approximately €17-20 billion in annual revenue, with Gucci historically accounting for approximately 50% of group revenue.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.